nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS1—malignant glioma	0.518	0.636	CbGaD
Phenylbutazone—PTGS2—malignant glioma	0.296	0.364	CbGaD
Phenylbutazone—CYP3A4—Temozolomide—malignant glioma	0.023	1	CbGbCtD
Phenylbutazone—SLC22A8—choroid plexus—malignant glioma	0.0201	0.33	CbGeAlD
Phenylbutazone—PTGIS—endothelium—malignant glioma	0.01	0.164	CbGeAlD
Phenylbutazone—PTGIS—blood vessel—malignant glioma	0.00925	0.151	CbGeAlD
Phenylbutazone—PTGIS—central nervous system—malignant glioma	0.00255	0.0417	CbGeAlD
Phenylbutazone—PTGIS—brain—malignant glioma	0.00203	0.0331	CbGeAlD
Phenylbutazone—PTGS1—endothelium—malignant glioma	0.00188	0.0308	CbGeAlD
Phenylbutazone—PTGS2—endothelium—malignant glioma	0.0018	0.0294	CbGeAlD
Phenylbutazone—PTGS1—blood vessel—malignant glioma	0.00173	0.0284	CbGeAlD
Phenylbutazone—PTGS2—blood vessel—malignant glioma	0.00166	0.0271	CbGeAlD
Phenylbutazone—SLC22A6—brain—malignant glioma	0.00107	0.0175	CbGeAlD
Phenylbutazone—Benzphetamine—POR—malignant glioma	0.00101	0.113	CrCbGaD
Phenylbutazone—PTGS2—embryo—malignant glioma	0.000988	0.0162	CbGeAlD
Phenylbutazone—PTGS1—telencephalon—malignant glioma	0.000841	0.0138	CbGeAlD
Phenylbutazone—Fosphenytoin—CYP2B6—malignant glioma	0.000836	0.0937	CrCbGaD
Phenylbutazone—SLC22A8—central nervous system—malignant glioma	0.000805	0.0132	CbGeAlD
Phenylbutazone—PTGS2—telencephalon—malignant glioma	0.000804	0.0132	CbGeAlD
Phenylbutazone—Sulfinpyrazone—CYP2B6—malignant glioma	0.000747	0.0837	CrCbGaD
Phenylbutazone—Trimethaphan—BCHE—malignant glioma	0.000713	0.0799	CrCbGaD
Phenylbutazone—SLC22A8—brain—malignant glioma	0.000639	0.0105	CbGeAlD
Phenylbutazone—PTGS2—medulla oblongata—malignant glioma	0.000632	0.0103	CbGeAlD
Phenylbutazone—PTGS1—spinal cord—malignant glioma	0.000589	0.00964	CbGeAlD
Phenylbutazone—PTGS2—midbrain—malignant glioma	0.000577	0.00945	CbGeAlD
Phenylbutazone—PTGS2—spinal cord—malignant glioma	0.000563	0.00922	CbGeAlD
Phenylbutazone—Clobazam—CYP2C18—malignant glioma	0.000546	0.0612	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS1—malignant glioma	0.000529	0.0593	CrCbGaD
Phenylbutazone—Phenytoin—CYP2C18—malignant glioma	0.000498	0.0558	CrCbGaD
Phenylbutazone—PTGS1—central nervous system—malignant glioma	0.000478	0.00782	CbGeAlD
Phenylbutazone—PTGS2—central nervous system—malignant glioma	0.000457	0.00748	CbGeAlD
Phenylbutazone—PTGS2—cerebellum—malignant glioma	0.000447	0.00731	CbGeAlD
Phenylbutazone—Modafinil—CYP2B6—malignant glioma	0.000417	0.0467	CrCbGaD
Phenylbutazone—Clobazam—CYP2B6—malignant glioma	0.000405	0.0454	CrCbGaD
Phenylbutazone—CYP3A4—central nervous system—malignant glioma	0.000399	0.00653	CbGeAlD
Phenylbutazone—Diphenhydramine—CYP2C18—malignant glioma	0.00039	0.0437	CrCbGaD
Phenylbutazone—PTGS1—brain—malignant glioma	0.000379	0.00621	CbGeAlD
Phenylbutazone—Methadone—CYP2C18—malignant glioma	0.000376	0.0422	CrCbGaD
Phenylbutazone—Phenytoin—CYP2B6—malignant glioma	0.000369	0.0414	CrCbGaD
Phenylbutazone—PTGS2—brain—malignant glioma	0.000363	0.00594	CbGeAlD
Phenylbutazone—Benzphetamine—CYP2B6—malignant glioma	0.000361	0.0405	CrCbGaD
Phenylbutazone—Modafinil—SLC6A3—malignant glioma	0.000355	0.0398	CrCbGaD
Phenylbutazone—Benzphetamine—SLC6A3—malignant glioma	0.000308	0.0345	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—malignant glioma	0.000303	0.0339	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2B6—malignant glioma	0.000289	0.0324	CrCbGaD
Phenylbutazone—Methadone—CYP2B6—malignant glioma	0.000279	0.0313	CrCbGaD
Phenylbutazone—Diphenhydramine—PTGS1—malignant glioma	0.00019	0.0213	CrCbGaD
Phenylbutazone—PTGIS—Metabolism—CAT—malignant glioma	6.7e-05	0.000723	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	6.67e-05	0.00072	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TERT—malignant glioma	6.66e-05	0.000719	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HLA-A—malignant glioma	6.66e-05	0.000719	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	6.62e-05	0.000715	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.59e-05	0.000712	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RTEL1—malignant glioma	6.58e-05	0.00071	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	6.54e-05	0.000706	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTP1—malignant glioma	6.5e-05	0.000702	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PDGFB—malignant glioma	6.5e-05	0.000702	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGFR1—malignant glioma	6.46e-05	0.000698	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	6.41e-05	0.000693	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	6.4e-05	0.000691	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	6.38e-05	0.000689	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—malignant glioma	6.37e-05	0.000688	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HIF1A—malignant glioma	6.37e-05	0.000687	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	6.36e-05	0.000687	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NCOR1—malignant glioma	6.33e-05	0.000683	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.19e-05	0.000668	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.16e-05	0.000665	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CAV1—malignant glioma	6.16e-05	0.000665	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ASMT—malignant glioma	6.11e-05	0.00066	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.09e-05	0.000658	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	6.04e-05	0.000653	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	6.03e-05	0.000652	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.97e-05	0.000645	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	5.87e-05	0.000634	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.8e-05	0.000626	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BAD—malignant glioma	5.79e-05	0.000625	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BCAN—malignant glioma	5.74e-05	0.00062	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOTCH1—malignant glioma	5.73e-05	0.000619	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—COX8A—malignant glioma	5.7e-05	0.000616	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD80—malignant glioma	5.62e-05	0.000607	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APC—malignant glioma	5.61e-05	0.000606	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGF—malignant glioma	5.54e-05	0.000599	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTPN11—malignant glioma	5.51e-05	0.000595	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BCAN—malignant glioma	5.44e-05	0.000588	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BRAF—malignant glioma	5.27e-05	0.000569	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.19e-05	0.00056	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CAV1—malignant glioma	5.16e-05	0.000557	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT2—malignant glioma	5.13e-05	0.000554	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.1e-05	0.000551	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—malignant glioma	4.98e-05	0.000538	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CD—malignant glioma	4.93e-05	0.000532	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.93e-05	0.000532	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.93e-05	0.000532	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DTX1—malignant glioma	4.92e-05	0.000532	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	4.88e-05	0.000526	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.85e-05	0.000524	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ASMT—malignant glioma	4.85e-05	0.000524	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.84e-05	0.000522	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.78e-05	0.000517	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.74e-05	0.000512	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGF2—malignant glioma	4.72e-05	0.00051	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.7e-05	0.000507	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CG—malignant glioma	4.7e-05	0.000507	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—RAF1—malignant glioma	4.7e-05	0.000507	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—malignant glioma	4.64e-05	0.000501	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—IDH2—malignant glioma	4.63e-05	0.0005	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BCAN—malignant glioma	4.56e-05	0.000492	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.55e-05	0.000491	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPARG—malignant glioma	4.53e-05	0.000489	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MDM2—malignant glioma	4.42e-05	0.000477	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RAF1—malignant glioma	4.4e-05	0.000475	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.37e-05	0.000471	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—malignant glioma	4.35e-05	0.00047	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP2B6—malignant glioma	4.35e-05	0.00047	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.34e-05	0.000469	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RTEL1—malignant glioma	4.34e-05	0.000468	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CB—malignant glioma	4.3e-05	0.000464	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.29e-05	0.000463	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—malignant glioma	4.26e-05	0.00046	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.23e-05	0.000457	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CD—malignant glioma	4.13e-05	0.000446	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—malignant glioma	4.09e-05	0.000442	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.08e-05	0.000441	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—IDH1—malignant glioma	3.98e-05	0.00043	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HEY2—malignant glioma	3.86e-05	0.000417	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SPHK1—malignant glioma	3.85e-05	0.000416	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—COX8A—malignant glioma	3.78e-05	0.000408	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP2C18—malignant glioma	3.77e-05	0.000408	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IDH1—malignant glioma	3.77e-05	0.000408	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTEN—malignant glioma	3.71e-05	0.000401	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.69e-05	0.000398	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—IDH2—malignant glioma	3.68e-05	0.000397	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CB—malignant glioma	3.6e-05	0.000389	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	3.58e-05	0.000387	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HEY1—malignant glioma	3.58e-05	0.000386	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—malignant glioma	3.57e-05	0.000385	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.56e-05	0.000384	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIST1H3B—malignant glioma	3.48e-05	0.000375	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.47e-05	0.000374	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2B6—malignant glioma	3.46e-05	0.000373	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.39e-05	0.000366	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.38e-05	0.000365	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—malignant glioma	3.32e-05	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.32e-05	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.24e-05	0.00035	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ASMT—malignant glioma	3.21e-05	0.000347	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAG2—malignant glioma	3.17e-05	0.000343	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—IDH1—malignant glioma	3.16e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.16e-05	0.000341	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.14e-05	0.000339	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.13e-05	0.000338	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.13e-05	0.000338	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTEN—malignant glioma	3.11e-05	0.000336	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—malignant glioma	3.09e-05	0.000333	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SPHK1—malignant glioma	3.06e-05	0.00033	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTT1—malignant glioma	3.05e-05	0.00033	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BCAN—malignant glioma	3.02e-05	0.000326	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—malignant glioma	3.02e-05	0.000326	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2C18—malignant glioma	3e-05	0.000324	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.99e-05	0.000323	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.88e-05	0.000311	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—malignant glioma	2.85e-05	0.000308	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.85e-05	0.000308	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.83e-05	0.000305	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.78e-05	0.000301	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—H3F3A—malignant glioma	2.68e-05	0.00029	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BCHE—malignant glioma	2.66e-05	0.000287	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC5A5—malignant glioma	2.63e-05	0.000284	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—malignant glioma	2.62e-05	0.000283	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.57e-05	0.000278	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAG1—malignant glioma	2.53e-05	0.000273	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—COX8A—malignant glioma	2.49e-05	0.000269	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.48e-05	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.48e-05	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FBXW7—malignant glioma	2.48e-05	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.46e-05	0.000266	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH2—malignant glioma	2.43e-05	0.000263	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTT1—malignant glioma	2.42e-05	0.000262	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.35e-05	0.000254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.29e-05	0.000248	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.29e-05	0.000247	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTGS1—malignant glioma	2.27e-05	0.000245	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.26e-05	0.000244	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—malignant glioma	2.19e-05	0.000237	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.15e-05	0.000232	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—malignant glioma	2.14e-05	0.000231	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ASMT—malignant glioma	2.12e-05	0.000229	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTP1—malignant glioma	2.12e-05	0.000228	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BCHE—malignant glioma	2.11e-05	0.000228	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH1—malignant glioma	2.09e-05	0.000226	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A5—malignant glioma	2.08e-05	0.000225	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAT—malignant glioma	2.06e-05	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SPHK1—malignant glioma	2.03e-05	0.000219	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BCAN—malignant glioma	1.99e-05	0.000215	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.98e-05	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.97e-05	0.000213	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NCOR1—malignant glioma	1.94e-05	0.00021	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—malignant glioma	1.94e-05	0.00021	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.87e-05	0.000202	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HES1—malignant glioma	1.85e-05	0.0002	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NCOR1—malignant glioma	1.84e-05	0.000199	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—malignant glioma	1.79e-05	0.000194	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRA—malignant glioma	1.76e-05	0.000191	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.7e-05	0.000184	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.7e-05	0.000184	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTP1—malignant glioma	1.68e-05	0.000181	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.64e-05	0.000178	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAT—malignant glioma	1.63e-05	0.000176	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HLA-A—malignant glioma	1.62e-05	0.000175	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—malignant glioma	1.62e-05	0.000175	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH2—malignant glioma	1.61e-05	0.000173	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—malignant glioma	1.6e-05	0.000173	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFB—malignant glioma	1.59e-05	0.000171	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAV1—malignant glioma	1.58e-05	0.000171	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR1—malignant glioma	1.58e-05	0.00017	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—malignant glioma	1.55e-05	0.000168	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NCOR1—malignant glioma	1.54e-05	0.000167	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.51e-05	0.000164	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.51e-05	0.000163	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS1—malignant glioma	1.5e-05	0.000162	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CAV1—malignant glioma	1.5e-05	0.000162	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.5e-05	0.000162	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—malignant glioma	1.44e-05	0.000156	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BAD—malignant glioma	1.41e-05	0.000153	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOTCH1—malignant glioma	1.4e-05	0.000151	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BCHE—malignant glioma	1.4e-05	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—malignant glioma	1.39e-05	0.00015	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.38e-05	0.000149	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH1—malignant glioma	1.38e-05	0.000149	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD80—malignant glioma	1.37e-05	0.000148	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—malignant glioma	1.37e-05	0.000148	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGF—malignant glioma	1.35e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTPN11—malignant glioma	1.34e-05	0.000145	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.34e-05	0.000144	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.31e-05	0.000141	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.31e-05	0.000141	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.29e-05	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—malignant glioma	1.29e-05	0.000139	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CD—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAV1—malignant glioma	1.26e-05	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT2—malignant glioma	1.25e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CD—malignant glioma	1.2e-05	0.00013	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.2e-05	0.00013	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—malignant glioma	1.15e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—malignant glioma	1.15e-05	0.000124	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.13e-05	0.000122	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTP1—malignant glioma	1.11e-05	0.00012	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CB—malignant glioma	1.11e-05	0.000119	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—malignant glioma	1.11e-05	0.000119	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—malignant glioma	1.1e-05	0.000118	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAT—malignant glioma	1.08e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MDM2—malignant glioma	1.08e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RAF1—malignant glioma	1.07e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—malignant glioma	1.06e-05	0.000115	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—malignant glioma	1.06e-05	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CB—malignant glioma	1.05e-05	0.000113	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOR1—malignant glioma	1.02e-05	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CD—malignant glioma	1.01e-05	0.000109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS1—malignant glioma	9.92e-06	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—malignant glioma	9.56e-06	0.000103	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BCHE—malignant glioma	9.22e-06	9.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.11e-06	9.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—malignant glioma	9.06e-06	9.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CB—malignant glioma	8.78e-06	9.48e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAV1—malignant glioma	8.33e-06	9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—malignant glioma	8.1e-06	8.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.96e-06	8.6e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.59e-06	8.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—malignant glioma	7.59e-06	8.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—malignant glioma	7.53e-06	8.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—malignant glioma	7.36e-06	7.95e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTP1—malignant glioma	7.34e-06	7.92e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—malignant glioma	7.32e-06	7.91e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAT—malignant glioma	7.14e-06	7.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—malignant glioma	6.96e-06	7.51e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—malignant glioma	6.74e-06	7.28e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOR1—malignant glioma	6.74e-06	7.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.67e-06	7.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—malignant glioma	6.39e-06	6.9e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.82e-06	6.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—malignant glioma	5.76e-06	6.22e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—malignant glioma	5.51e-06	5.95e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAV1—malignant glioma	5.49e-06	5.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—malignant glioma	5.35e-06	5.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—malignant glioma	5.22e-06	5.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—malignant glioma	5.02e-06	5.43e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.01e-06	5.4e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—malignant glioma	4.83e-06	5.22e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.4e-06	4.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—malignant glioma	4.37e-06	4.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.84e-06	4.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—malignant glioma	3.8e-06	4.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.54e-06	3.83e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—malignant glioma	3.31e-06	3.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—malignant glioma	2.9e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.34e-06	2.52e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—malignant glioma	1.91e-06	2.06e-05	CbGpPWpGaD
